It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, ...

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Hims and Hers Health beat Wall Street estimates for third-quarter revenue on Monday, as the telehealth company added ...

Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

On behalf of our sponsors at Tonum Health, we're leaning about the millions of Americans using weight loss medications like Ozempic and Wegovy. There's now a growing conversation around what happens ...

In June, Novo ended a partnership with Hims & Hers that provided access to Wegovy through the pharma's Novocare Pharmacy because Hims & Hers was trying to skirt legal restrictions on compounding ...

Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO ...

But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful ...

Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid ...

Groundbreaking GLP-1 drugs like Ozempic, Mounjaro and Wegovy are revolutionising weight loss, with studies showing ...

Plus, the Trump administration is expected to release finalized Medicare payment rules for doctors and hospitals as soon as next week.